We used fluorescent probes and electron paramagnetic resonance (EPR) to study the mechanism(s) underlying ROS production by endothelial cell mitochondria and the action of mitoquinol, a mitochondrial targeted antioxidant. ROS measured by fluorescence resulted from complex I superoxide released to the matrix and converted to H 2 O 2. In contrast, EPR largely detected superoxide generated at complex III and effluxed outward. ROS fluorescence by mitochondria fueled by the complex II substrate, succinate, was substantial but markedly inhibited by rotenone. Superoxide, detected by EPR, in succinate-fueled mitochondria was not inhibited by rotenone and likely derived from semiquinone formation at complex III. Mitoquinol decreased H 2 O 2 fluorescence by succinate-fueled mitochondria but had little effect on the EPR signal for superoxide. This was not associated with a detectable decrease in membrane potential. Mitoquinol markedly enhanced ROS fluorescence in mitochondria fueled by the complex I substrates, glutamate and malate. Inhibitor studies suggested that this occurred in complex I, at a Q binding pocket(s). The above effects of mitoquinol were determined in mitochondria isolated and subsequently exposed to the targeted antioxidant. However, similar effects were observed in mitochondria after antecedent exposure to mitoquinol/mitoquinone in culture suggesting that the agent is retained after isolation of the organelles.
INTRODUCTION
Control of reactive oxygen species (ROS) 1 in endothelial cells is particularly important since endothelial dysfunction, which may be triggered by ROS (1) , is a major factor contributing to the development of atherosclerotic heart disease (2-4). Moreover, mitochondrial oxidative damage may underlie problems including the vascular and neurologic complications of diabetes, cell damage in degenerative diseases, and aging (5) (6) (7) (8) (9) . Reactive oxygen derived from endothelial cell mitochondria has also been implicated in the metabolic pathways leading to the microvascular complications of diabetes (6) .
Mitochondrial electron transport generates substantial amounts of superoxide derived from electron leaks as substrates are metabolized (10) . The process may have adverse consequences as evidenced by observations in mice lacking the mitochondrial enzyme manganese superoxide dismutase (MnSOD). These mice develop dilated cardiomyopathy and live less than two weeks (11) . The major sites of superoxide production have been somewhat controversial but there is evidence that most derives from complex I and III (12) . There is also evidence that complex I superoxide is released exclusively to the matrix side of the inner membrane, whereas complex III likely generates superoxide to both the matrix and intermembrane space (13) (14) (15) .
The likely role of ROS in human disease has led to efforts at prevention through antioxidant therapy. However, the therapeutic use of antioxidants in vivo, particularly in human studies directed at vascular events, has been disappointing (16) . Possible reasons for this include inadequate dosing due to concerns over toxicity and inability to deliver agents to target sites of ROS production. Hence, efforts are underway to develop effective antioxidant compounds targeted to mitochondria. One approach to this involves the synthesis of compounds linking agents such as redox forms of Q compounds (ubiquinol and ubiquinone) or vitamin E to compounds like triphenylphosphonium, a lipophilic cation avidly taken up into the relatively negative mitochondrial matrix (17, 18) . In fact, we and several others have used the tetraphenylphosphonium ion to measure mitochondrial membrane potential (19, 20) .
One such compound, an alkyltriphenylphosphonium cation, termed mitoQ (mitoquinol or mitoquinone or a mixture of these redox forms), consists of compound Q covalently bound to the cation triphenylphosphonium. By virtue of its delocalized positive charge, mitoQ accumulates several hundredfold in mitochondria (18, 21) and has been used to modulate ROS in the mitochondrial matrix (22) .
Although mitoQ appears to have protective effects in certain cell types, the mechanism of action is not well defined and appears complex. A major action may be to decrease lipid peroxidation by virtue of the quinol moiety acting as a chain breaking antioxidant (23) . Mitochondria-targeted antioxidants protected Friedreich Ataxia fibroblasts, in which glutathione synthesis was blocked, from oxidative stress (24) and mitoQ reduced telomere shortening in fibroblasts exposed to oxidative stress (25) . In bovine aortic endothelial (BAE) cells, mitoQ reduced oxidative damage in cells stressed by 25 mM glucose and glucose oxidase (26) . Moreover, mitoQ also reduced ROS and ERK2 activation in endothelial cells after hypoxic stress (27) .
There is currently no information concerning the mitochondrial sites of ROS production or about the effects of mitochondrialtargeted antioxidants in mitochondria of vascular cells. There is also no information concerning the effects of these targeted compounds in mitochondria isolated from cells subject to prior antioxidant treatment in culture.
To better understand the mechanism(s) and site(s) of ROS production by endothelial mitochondria we examined ROS production under different substrate and inhibitor conditions. We assessed ROS in two ways; as fluorescence produced by hydrogen peroxide and as superoxide specifically determined by electron paramagnetic resonance spectroscopy (EPR). As our data will show, these two methods differ in regards to what they measure. To learn more of the action of targeted quinols/quinones in endothelial mitochondria, we examined ROS production upon addition of these compounds directly to mitochondria as well as after antecedent exposure of BAE cells to these compounds in culture. Control compounds included non-targeted ubiquinone and decyltriphenylphosphonium (dTPP), which is identical to mitoquinone and mitoquinol but lacks the quinone/quinol group (28) .
EXPERIMENTAL PROCEDURES

Reagents and supplies
Mitoquinone and mitoquinol were synthesized from commercially available 11-bromoundecanoic acid and 2,3-dimethoxy-5-methyl-1,4-benzoquinone as described (18, 21) . Other reagents, kits, and supplies were as specified or purchased from standard sources.
Animals
Animals were fed and maintained according to standard NIH guidelines and the protocol was approved by our institutional Animal Care Committee. Normal C57Bl/6 mice (age 99 ± 19 days, 8 males and 2 females) were sacrificed by intraperitoneal injection of pentobarbital followed by cardiac puncture in order to obtain hindlimb muscle tissue for preparation of mitochondria. Cell culture BAE cells were grown in medium M199 (Invitrogen, Grand Island, NY) supplemented with MEM amino acids (Invitrogen), penicillin/streptomycin (Invitrogen), MEM vitamins (Sigma, St. Louis, MO), and 20% fetal bovine serum (Hyclone, Logan, Utah) as described (29) . Cells were grown to near confluence in 150 cm 2 flasks between passage 6 and 12. For experiments involving mitochondrial-targeted antioxidants administered to intact cells, 1µM concentrations of mitoquinone, mitoquinol, ubiquinone, dTPP, or methyltriphenylphosphonium (mTPP) or vehicle (ethanol) were then added and the cells incubated for 24h before isolation of mitochondria.
Isolation of mitochondria
Cells were washed with phosphate buffered saline (PBS) and scraped. Collected cells were homogenized using a Dounce homogenizer in ice-cold homogenization buffer (0.25 M sucrose, 5 mM HEPES, 0.1 mM EDTA, pH 7.2) with 0.1% fatty acid-free bovine serum albumin (BSA). For muscle mitochondria, the tissue was minced and processed using a Potter-Elvehjem tissue grinder and subsequently by a ground glass homogenizer. The homogenate was centrifuged at 1000 X g for 10 min. The pellet was discarded and the supernatant was centrifuged again at 10,000 X g for 10 min to obtain the mitochondrial pellet. The resulting pellet was then washed three times in homogenization buffer without BSA and resuspended in media as described below. Protein was determined by the Bradford method (BioRad, Hercules, CA). Mitochondria prepared in this way were of good quality as documented by an increase in respiratory rate of 4-6 fold after addition of carbonyl cyanide p-[trifluoromethoxy]-phenyl-hydrazone (FCCP) as an uncoupler.
Mitochondrial hydrogen peroxide
Mitochondria were studied during state 4 respiration, under which circumstance oxygen radical formation is enhanced as electron flow leads to high potential unmitigated by ATP generation (30 
Mitochondria superoxide generation
As in the case of fluorescent detection, mitochondria were studied during state 4 respiration. Electron Paramagnetic Resonance (EPR) spectra were recorded using a Bruker EMX EPR spectrometer operating in X band and equipped with a high sensitivity resonator ER 4119HS. Samples were prepared at room temperature in 0.3mL of respiratory buffer with 0.0688M 5,5-dimethyl-l-pyrroline-N-oxide (DMPO), and 0.12 mg isolated mitochondria. Respiration was initiated with the addition of substrate (succinate or glutamate plus malate) and samples were pre-incubated for 5 minutes in a 37 o C water bath. Reactions were transferred to a flat aqueous EPR cell and the spectra recorded at room temperature using the following instrument settings: microwave power 40 mW, modulation amplitude 2 G, receiver gain 2 x 10 5 , conversion time 40.96 ms, time constant 81.92 ms, and scan rate 80G/41.92 s. Spectra shown are the average of 7 to 10 scans.
Oxygen utilization and mitochondrial membrane potential
The rate of respiration of isolated mitochondria (0.2 -0.4 mg protein/ml) was determined as we previously described (19, 31) . Concurrently, we assessed mitochondrial inner membrane potential based on the distribution, (inside and external to the mitochondrial matrix), of the lipophilic cation triphenylphosphonium (TPP + ) as we previously described (19) . To determine the concentration of TPP + inside the mitochondrial matrix, it is necessary to know the mitochondrial matrix volume and the extent to which TPP + is bound to mitochondrial protein as opposed to freely present within the matrix. Mitochondrial matrix volumes and the TPP+ binding correction, under the conditions of incubation, were determined as we have previously reported (20) .
Kinetic relationship of proton flux to membrane potential
The relationship of H + flux to mitochondrial membrane potential (kinetics of the proton leak) has been considered an optimal assessment of mitochondrial uncoupling (32, 33) . This was accomplished through simultaneous recording of oxygen consumption and potential as we have previously carried out using electrodes sensitive to oxygen and to the distribution of the tetraphenylphosphonium ion (TPP + ) (19, 20) . Mitochondria were incubated in respiratory buffer plus 5 μm rotenone to inhibit electron entry at Complex-I, and 0.1 μm nigericin to abolish the ΔpH (34) across the mitochondrial membrane]. H + flux, under these conditions, is proton leak dependent and, with succinate as fuel, follows a 6:1 stoichiometry (H + /O) with oxygen consumed (32, (35) (36) (37) . Succinate (5 mM) was added followed by malonate in incremental amounts to final concentrations of 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 1.0, and 2.0 mM to inhibit succinate dehydrogenase, thereby, decreasing electrons available for the transport system and creating a range of membrane potentials (38) .
Measurement of membrane potential by isotopic assessment of TPP + distribution
Reaction tubes contained 40μg of mitochondria, 2μM oligomycin, 6μM tetraphenylphosphonium chloride, and 40nM tetra [ 3 H]phenylphosphonium bromide (1.4 uCi/ml) in a volume of 100μL of respiration medium plus 0.1% BSA. The microfuge tubes were incubated for 5 minutes at 37 o C in the presence of 5mM succinate or 5mM succinate plus 2.5μM FCCP. The tubes were then centrifuged at room temperature for 4 minutes at 10,000 x g. 90μL of each supernatant was removed for liquid scintillation counting. Succinate driven mitochondrial TPP + uptake was assessed as the difference in counts recovered between the succinate + FCCP supernatant and the succinate alone supernatant. Potential was then calculated based on the Nernst equation. Each individual assay was carried out in duplicate and mean values determined.
Measurement of Complex I (NADH-ubiquinone oxidoreductase) activity in BAE cell mitochondria
Activity was determined as described (39) by following the decrease in absorbance due to NADH oxidation at 340 nm. Activity was measured for 5 minutes in the presence of excess NADH and ubiquinone. Mitochondria we freeze thawed three times to disrupt membranes in order to release activity.
Statistics
Differences between groups were determined by ANOVA or t-test with correction for multiple groups using commercial software (GraphPad Prism, GraphPad Software, Inc., San Diego, CA).
RESULTS
H 2 O 2 production from isolated BAE cell mitochondria assessed by fluorescence:
H 2 O 2 was assessed as relative Amplex Red (figure 1A) or DCF (figure 1B) fluorescence in mitochondria isolated from BAE cells and fueled by succinate, a complex II substrate. Using either fluorescent probe, ROS production was markedly inhibited by the complex I inhibitor rotenone. Addition of the complex III inhibitor, antimycin A, mildly decreased ROS as assessed in this manner. H 2 O 2 production in succinate fueled mitochondria was compared to that in the presence on the complex I substrates, glutamate plus malate (figure 1C). In this case H 2 O 2 was quantified in molar terms based on fluorescence of Amplex Red in the presence of a standard curve. H 2 O 2 production was much less in the presence of the complex I substrates. Rotenone did not alter H 2 O 2 production in this circumstance. The experiments in figure 1C were also carried out in mouse hindlimb muscle mitochondria (figure 1D). Succinate driven H 2 O 2 production was greater in muscle mitochondria. In contrast, relatively little H 2 O 2 was generated by glutamate/malate fueled mitochondria unless rotenone was added.
There was minimal non-specific fluorescence due to rotenone or antimycin A. Addition of these compounds to respiratory buffer without mitochondria or with mitochondria in the absence of substrate altered fluorescence only about 5% and correction for this effect would not reduce the significance of the differences observed.
Superoxide production from isolated BAE cell mitochondria assessed by EPR spectroscopy:
H 2 O 2 production as measured by our fluorescent probes (see above) should derive largely from matrix superoxide released at complex I and converted to H 2 O 2 by matrix superoxide dismutase (SOD) (13) . Superoxide, effluxed outward to the cytoplasmic side should not be detected by our fluorescent probes unless converted to H 2 O 2 by exogenous SOD which was not present in the incubation medium. On the other hand, superoxide effluxed directly outward should be detectable by EPR spectroscopy. OH spectra could possibly arise directly from the hydroxyl radical rather than the rapid decay of the superoxide adduct, DMPO/ . OOH. However, addition of SOD abolished the spectra (figure 2) indicating that formation of DMPO/ . OH was entirely mediated by the superoxide radical.
Figure 2 reveals marked differences in reactive oxygen as assessed by EPR measurement of superoxide compared to fluorescent measurement of H 2 O 2 . As shown in figure 2, succinate-fueled mitochondria generated superoxide substantially above that in the absence of substrate but, as opposed to fluorescent detection of H 2 O 2 (figure 1), there was no inhibition by rotenone. Moreover, while antimycin A markedly increased the EPR signal (figure 2F), antimycin decreased H 2 O 2 by fluorescence ( figure  1 ). The spectra shown in figure 2 are representative of at least five repetitions for each condition studied (see below).
Effects of mitochondrial targeted antioxidant compounds added to isolated BAE mitochondria on H 2 O 2 production detected by fluorescence:
ROS were assessed both as H 2 O 2 fluorescence and as superoxide by EPR. Figure 3A shows that mitoquinol and mitoquinone reduced H 2 O 2 production by succinate fueled mitochondria. The non-targeted compound, ubiquinone, had no effect. Figure 3B shows that, in sharp contrast to the effect of mitoquinol in succinate fueled mitochondria, mitoquinol markedly increased H 2 O 2 production by mitochondria fueled by the complex I substrates, glutamate and malate. When added to mitochondria in the absence of substrate mitoquinol, mitoquinone, dTPP, and ubiquinone all increased Amplex Red fluorescence, but by less than 10% of that observed in succinate fueled mitochondria. Moreover, there was essentially no difference between the effects of the individual compounds and, therefore, non specific fluorescence can not account for the observed differences between these compounds in the presence of substrate.
Data from a subsequent series of experiments (figure 4) confirm the effect of mitoquinol in glutamate/malate-fueled mitochondria and include non-targeted ubiquinone and decyl TPP as controls, neither of which shared the effect of mitoquinol. Mitoquinone, the oxidized form of mitoQ, had similar but lesser effects than mitoquinol. As seen in figure 4, we also examined the effect of two inhibitors of electron transfer upon ROS generation triggered by mitoquinol and mitoquinone. Stigmatellin inhibits electron transfer at the Q P center near the outer face of complex III where electrons from reduced ubiquinone are accepted. This agent markedly reduced the effect of mitoquinol and mitoquinone on ROS production. Rotenone, a Q site inhibitor in complex I, likewise reduced the effect of mitoquinol and mitoquinone on ROS but to a lesser extent than stigmatellin. Stigmatellin, more than rotenone, induced non specific fluorescence. When added to mitochondria in the absence of substrate fluorescence increased approximately 40%. Therefore, the data in figure two were corrected for non-specific fluorescence by subtracting out the effect of stigmatellin and rotenone on fluorescence by mitochondria in the absence of substrate.
The effect of the complex I inhibitor, rotenone, to decrease H 2 O 2 fluorescence by succinate fueled mitochondria (figure 3) suggests that the H 2 O 2 fluorescent signal derives from reverse electron transport (41, 42) . Mitoquinol had a similar effect to reduce fluorescence by succinate fueled mitochondria. So it could be that mitoquinol reduced H 2 O 2 fluorescence by reducing potential, to which reverse electron transport is highly sensitive (5, 43) . However, as shown in figure 5 , this does not appear to be the case, as mitoquinol did not alter membrane potential in succinate-fueled mitochondria incubated under the conditions of figure 4 . DecylTPP, unlike mitoquinol, did reduce potential in succinatefueled mitochondria (figure 5). So for dTPP, its effect on ROS in succinate-fueled mitochondria (figure 3) may reflect reduced potential. Notably, dTPP, unlike mitoquinol or mitoquinone, had no effect to increase H 2 O 2 production by glutamate/malate-fueled mitochondria (figure 4).
Effects of mitochondrial targeted antioxidant compounds added to isolated BAE mitochondria on superoxide production by EPR spectroscopy :
Figure 6 depicts superoxide production by EPR under several different conditions. Thirty-one mitochondrial preparations were examined in individual experiments (each on a separate day) with each experiment including the succinate alone condition as well as mitochondria exposed to the various conditions indicated. The data were normalized to the mean EPR signal intensity for the succinate alone condition. The results show that mitoquinol as well as ubiquinone and rotenone had no significant effects to alter superoxide production in succinate-fueled BAE mitochondria. Antimycin markedly enhanced superoxide by succinate-fueled mitochondria while stigmatellin decreased superoxide. These effects of antimycin and stigmatellin were as expected and serve as controls validating the methodology and responsiveness of the mitochondria. In glutamate/malate fueled mitochondria, as in succinate fueled mitochondria, mitoquinol did not significantly alter superoxide by EPR. Rotenone decreased superoxide in glutamate/malate fueled mitochondria as expected for the complex I substrates, wherein rotenone should limit electron transport through complex I and secondarily to complex III.
Effects of stigmatellin and MitoQ on complex I (NADH-ubiquinone oxidoreductase) activity:
Based on reported data for muscle mitochondria (44), we thought that stigmatellin, at the concentration we utilized, would specifically block complex III. However, to assess this we measured the effect of 80 nM stigmatellin on complex I activity. We also asked whether mitoquinol or mitoquinone might decrease endothelial cell mitochondrial complex I activity and, thereby, impact ROS production on this basis. As seen in table 1 none of these agents affected enzyme activity. As expected, rotenone reduced activity by 69 % consistent with the expected degree of rotenone sensitivity in mitochondria from various other tissues and cells (39).
Effects of mitochondrial targeted antioxidant compounds added to intact BAE cells prior to isolation of mitochondria
We further addressed the issue of the mitochondrial effects of mitoQ after addition to intact BAE cells, rather than to already isolated mitochondria. Cells were exposed to mitoquinone or mitoquinol or to control compounds for 24 h before isolation and incubation of the mitochondria in vitro under different substrate conditions. Mitoquinone or mitoquinol, 1 μM, did not alter the appearance or rate of growth of BAE cells after 24 h exposure (not shown). The effects of these agents were similar to those observed when the compounds were added to mitochondria after isolation. As shown in figure 7A , mitoQ, either in the quinol or quinone form, reduced H 2 O 2 production when the mitochondria were fueled by the complex II substrate, succinate. This was not observed for mitochondria isolated from cells treated with non-targeted ubiquinone. Figure 7A also shows that succinate driven ROS production by mitochondria of the cells treated with vehicle or non-targeted ubiquinone was rotenone sensitive. Figure 7B shows that mitoquinone, but not dTPP, increased H 2 O 2 production by mitochondria fueled by glutamate and malate.
As was the case for mitochondria exposed to mitoquinol after isolation, figure 7A suggests that succinate driven H 2 O 2 generation in mitochondria of BAE cells resulted from reverse electron transport (41,42). As discussed above, reverse electron transport is very sensitive to mitochondrial membrane potential and to "mild" uncoupling (5, 43) . So the effect of mitoquinol and mitoquinone in figure 7A could have been due to reduced potential and "mild" uncoupling. To examine this, and also to address the possible effect of uncoupling (5,43), we assessed the kinetics of respiration and potential in BAE mitochondria isolated from cells after 24 h treatment (of the cells) with either vehicle, dTPP, mitoquinone, or the methylated form of TPP (mTPP). As shown in figure 7C , mitoquinone had no effect on these kinetics. Only dTPP reduced potential and shifted the curve of respiration versus potential up and to the left consistent with mitochondrial uncoupling (32, 33) . Since we used a TPP + electrode to detect mitochondrial potential, a question arises as to whether the targeted antioxidant compounds, which contain a TPP moiety, may have interfered with electrode potential. This would not seem very likely since the mitochondria were isolated from cells previously treated with the targeted compounds and washed after isolation. Moreover, these results are consistent with mitochondrial inner membrane potential by distribution of the radiolabeled triphenylphosphonium ion as determined in mitochondria exposed to the targeted antioxidants after isolation (figure 5).
DISCUSSION
Endothelial cell dysfunction has been implicated in vascular and degenerative disease and mitochondrial ROS are thought to play an important pathogenic role (1) (2) (3) (4) (5) (6) (7) (8) (9) 45) . This has led to efforts to develop antioxidant compounds targeted to mitochondria (46, 47) . Although mitochondria are likely the major site of ROS generation (28, 48) in most cells, little is known about ROS production within endothelial cell mitochondria. Here we report new information concerning the mechanism leading to endothelial ROS production at the mitochondrial level and the means by which targeted quinol/quinone compounds may act on endothelial cell mitochondria. Figure 8 schematically depicts electron transport and the effects of the substrates and inhibitors used in our studies. Based on our current findings, the figure also depicts proposed sites of ROS production in BAE mitochondria and sites of action for mitoquinol and mitoquinone. The rationale for this is as follows.
Our results show that fluorescent H 2 O 2 probes and EPR spectroscopy detected ROS in different fashion. This was evident in that the complex I inhibitor, rotenone, markedly decreased succinate driven ROS production as detected by fluorescence, but had no effect on superoxide production by EPR spectroscopy. Moreover, antimycin markedly increased succinate driven superoxide by EPR, but decreased ROS by fluorescent detection. These results are not discrepant. Amplex Red and DCF detect superoxide indirectly. When added to isolated mitochondria, these probes will detect H 2 O 2 generated from superoxide by MnSOD, which is abundant in the mitochondrial matrix. H 2 O 2 generated in this way will diffuse out of mitochondria and react with horseradish peroxidase in the incubation medium to trigger fluorescence. H 2 O 2 produced in this way derives largely from matrix superoxide released at complex I (13) . Superoxide effluxed outward and away from the matrix will not be detected by this fluorescent method in the absence of SOD. In contrast to our fluorescent probes, our EPR spin trap, DMPO, should directly detect superoxide effluxed outward. Superoxide produced in this fashion should largely derive from the Q cycle at complex III (13) . The EPR signal so detected is highly specific for superoxide or the hydroxyl radical both of which react with DMPO to generate the same EPR spectra. However, the spectra reported here represent superoxide as they could be completely abolished by added SOD. Since DMPO will not easily penetrate mitochondria and because matrix superoxide is rapidly converted to H 2 O 2 , our spin trap should not detect superoxide released to the matrix as occurs at complex I.
Thus, both the data in figures 1 and 2 and the theoretical considerations above imply that EPR spectroscopy and fluorescent probes can be used in complementary fashion, as we have done, to comprehensively examine endothelial ROS generation from mitochondrial complex I (fluorescence) and complex III (EPR). Theoretically we could have assessed complex III superoxide release to the cytoplasmic side of isolated mitochondria simply by measuring H 2 O 2 production as fluorescence in the presence and absence of added SOD. However, we found marked nonspecific interference with fluorescence when SOD was added to isolated mitochondria. We do acknowledge that H 2 O 2 production in the presence and absence of SOD has been effectively carried out in assessing the topology of muscle, heart, and liver mitochondria (13) . However, that required mathematical correction for considerable fluorescent interference.
Our data (figure 1) show that BAE mitochondria consuming the complex II substrate, succinate, generate matrix superoxide released at complex I and detected as H 2 O 2 fluorescence. This suggests that ROS so produced resulted from reverse electron transport which is confirmed by the marked inhibition by the complex I inhibitor rotenone ( figures 1 and 3) . Similar findings have been reported for muscle, heart, and brain mitochondria (41, 44, 49) .
In contrast to the amount of complex I ROS produced by succinate-fueled BAE mitochondria, consumption of the complex I substrates, glutamate and malate, generated considerably less (figures 1 and 2) . However, this amount was clearly detectable, an observation that which differs from isolated muscle, heart, and brain mitochondria (41, 44, 49) which generate very little or no H 2 O 2 when complex I substrates are oxidized. Complex I substrates in muscle, heart, and brain mitochondria generate more H 2 O 2 when rotenone is added, possibly due to downstream inhibition of a Q-cycle type mechanism in complex I, similar to the known effect of antimycin at complex III (44) . Our studies contrasted in that we did not see an increase in H 2 O 2 production when rotenone was added. This was not due to technical differences since, using the same methodology, we did see a stimulatory effect of rotenone in mitochondria isolated from normal mouse muscle tissue ( figure 1D ). Hence a complex I rotenone sensitive Q-cycle mechanism may not be operative, or is operative in a rotenone insensitive manner, in endothelial cell mitochondria.
Our EPR data (figures 2 and 6) show that BAE mitochondria fueled with either complex I or complex II substrates generate superoxide effluxed outward at complex III. This likely results from semiquinone formation in the complex III Q-cycle ( figure 8 ). This is supported by the stimulatory effect of antimycin A, which inhibits downstream reduction and consequently prolongs the lifetime of the semiquinone radical and the inhibitory effect of stigmatellin which blocks electron transport through complex III (figure 8).
Since mitochondrial ROS appear important in endothelial cell mediated vascular disease, efforts are underway to develop effective means of antioxidant treatment. As discussed above, one means is to develop mitochondrialtargeted antioxidants such as mitoQ. Our current findings provide new insight as to how these compounds modulate ROS in endothelial cell mitochondria. Based on our EPR results, there appears to be little effect of mitoquinol on superoxide generated at complex III ( figure 6 ). This is compatible with a report indicating lack of restoration of respiration by MitoQ in ubiquinone deficient yeast mitochondria due to the inability of mitoQ to be oxidized by complex III (28) .
Although our EPR results showed that mitoquinol did not alter superoxide production at complex III, mitoquinol markedly reduced H 2 O 2 generation in succinate fueled mitochondria ( figures 3, 4) . Thus, from the above discussion, mitoquinol appears to inhibit reverse electron transport to complex I. On the other hand, mitoquinol strongly enhances forward transport through complex I as manifest by the effect on H 2 O 2 generation in the presence complex I substrates (figures 3, 4).
How might mitoquinol and mitoquinone act to manifest the above effects on complex I superoxide formation? The answer to this is somewhat limited in that the physiology of electron transport at complex I is incompletely understood. However, our data do suggest certain mechanistic possibilities. Mitoquinol and mitoquinone and related compounds are felt to have antioxidant properties initiated by formation of a semiquinone as an initial step in scavenging an electron from peroxide species, thereby, initiating a chain breaking effect on lipid peroxidation (23) . Moreover, mitoquinol and mitoquinone are believed to be mobile but situated in the mitochondrial inner membranes with the nonpolar (TPP) moieties within lipid bilayers and the quinone/quinol portions extending inward (28). So, it is possible that the quinone/quinol portions react during forward electron transport at a Q binding site wherein conversion of mitoquinol to the reactive semiquinone radical would lead to enhancement of superoxide production with release to the matrix and conversion to H 2 O 2 . In this respect, mitoquinol is envisioned as an analogue of ubiquinol, but upon semiquinone formation would be less susceptible to further reduction leading to a longer half-life and, hence, greater superoxide generation. The effect of stigmatellin is compatible with this. Stigmatellin, by blocking electron transport through complex III, without inhibition of complex I, should lead to reduction of all upstream electron carriers back to NADH. This would limit semiquinone formation by preventing reduction of mitoquinol and, for that matter, ubiquinol. The effect of the Q site, by guest on August 17, 2017 http://www.jbc.org/ Downloaded from complex I inhibitor, rotenone, to inhibit mitoquinol/mitoquinone induced ROS generation during forward transport is compatible with this and supports an effect at a Q-binding pocket. However, rotenone would not work in a way that blocks reduction of the semiquinone, as is the case for antimycin in the Q cycle of complex III, since that would increase rather than decrease ROS. Rather, rotenone must block the interaction of mitoquinol/mitoquinone with the Q binding site in some other fashion.
Thus, our data on the action of mitoQ and ROS during forward electron transport implies a prooxidant rather than antioxidant effect. However, it is important to note that this does not imply deleterious effects of mitoQ in terms of cellular and mitochondrial oxidative stress. This is because, as stated above, formation of a semiquinone by mitoQ would scavenge an electron from peroxide species impairing lipid peroxidation (23) . This would provide benefit at the expense of superoxide molecules against which cellular defenses efficiently exist.
Although rotenone markedly reduced the effect of mitoquinol/mitoquinone on ROS generation by forward transport, this effect of rotenone was less than that of stigmatellin ( figure  4) . Thus, the effect of rotenone to block interaction at a Q binding pocket is either not as potent as the effect of stigmatellin or mitoquinol/mitoquinone may act at an additional site, likely upstream, as the rotenone site is felt to be in the distal position of the complex (figure 8).
Completely opposite to their effect in glutamate and malate fueled mitochondria, mitoquinol (figures 3 and 7) and mitoquinone (figure 7) reduce ROS generation in succinate fueled-mitochondria. Unfortunately, we can not easily explain the mechanism underlying this opposite action. We considered that the action of mitoQ on ROS during reverse electron transport might occur through reduction in mitochondrial inner membrane potential and "mild" uncoupling to which reverse electron transport is highly sensitive (43, 50) . However, this was not evident either as uncoupling of respiration as assessed by electrochemical means (figure 7) or by distribution of a radiolabeled lipophilic cation (figure 5). We do acknowledge that we can not completely rule out that mitoQ does reduce potential to an undetectable extent and that reverse transport happens to be exquisitely sensitive to this reduction. However, another possibility considers that mitoQ is driven to the reduced state by reverse electron flow and prevented form forming a semiquinone. It would then seem feasible that reduced mitoQ (mitoquinol) could act in some way, possibly like rotenone, at a Q site, to block reverse transport.
We did observe that the compound, dTPP, which represents mitoQ with the 10 carbon chain but no quinol/quinone moiety did reduce potential (figures 5 and 7) and did reduce succinate driven ROS (figures 3 and 7) . Notably dTPP, unlike mitoQ, had no effect to enhance ROS during forward electron transport (figures 4 and 7) demonstrating that that the quinol/quinone moiety is essential for action on ROS during forward transport.
Our results also suggest that some cycling of mitoQ must occur within BAE mitochondria. This is because our studies revealed similar effects of mitoquinol compared to mitoquinone on ROS generation (figures 4 and 7A). So, these agents, in effect, appear to be "buffered" with respect to redox state by the respiratory chain through redox cycling between mitoquinol and mitoquinone.
As seen in figure 7 , the effects of mitoquinone and mitoquinol are evident in mitochondria isolated after antecedent exposure of the intact cells in culture to the targeted antioxidants. In this regard, mitoquinone and mitoquinol added to the culture media had actions similar to those evident when added directly to isolated mitochondria (figures 3, 4, and 7). Since the mitochondria of the antecedent treated cells were washed after isolation (and the cells were washed prior to isolation of the mitochondria), this suggests that the targeted compounds remained in mitochondria after isolation. Although, we have not ruled out concurrent effects on gene expression or other cellular processes, the similarity of the effects of mitoquinol and mitoquinone whether added to cells in culture or to isolated mitochondria suggests that the effects were due to persistence of the compounds in mitochondria.
In summary, our data suggest the following. Superoxide production at complex I in BAE mitochondria results from reverse electron transport and, to a lesser extent, by forward transport. Superoxide is also generated at the Q cycle in complex III. MitoQ acts in complex I to block ROS generated by reverse transport but markedly enhance superoxide production derived from forward electron transport. This likely results from action at a rotenone sensitive Q binding site and, possibly, another upstream site(s). Moreover, our data show that mitoQ has persistent effects evident in mitochondria isolated from cells after antecedent exposure in culture suggesting that the targeted antioxidant is taken up and maintained in mitochondria for at least 24h. production (mean ± sem) quantified by Amplex Red fluorescence relative to known standards in isolated BAE mitochondria incubated in respiration buffer and fueled with glutamate plus malate in the presence of 1μM concentrations of the compounds indicated on the x-axis. For each group along the x-axis, mitochondria were exposed to vehicle (veh), 5 μM rotenone (rot), or 80 nM stigmatellin (stig). * p < 0.01 compared to glut + mal in mitochondria treated with a Q compound or dTPP, † p < 0.01 compared to veh and compared to stig in mitochondria treated with mQL, ‡ p < 0.05 compared to veh and compared to stig in mitochondria treated with mQN. Figure 5 . Inner membrane potential (mean ± sem) determined by the distribution of the lipophilic cation, tetra [ 3 H]phenylphosphonium bromide, as described under methods. Mitochondria were incubated for 5 minutes in the presence of succinate (5mM) in respiratory buffer with vehicle or 1μM concentrations of methyl triphenylphosphonium (mTPP), decyl triphenylphosphonium (dTPP), or mitoquinol (mQL) as indicated on the x-axis. * p < 0.01 compared to vehicle and mTPP and < 0.05 compared to mQL, n = 4 for each condition. 
